Antimetabolites in Glaucoma Surgery

Volume 34, Number # 3, 2006 Series

(1) The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery study. Am J Ophthalmol 1996;121:349-66.

(2) Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317-321.

(3) Khaw PT, Ward S, Porter A, Grieson I, Hitchings RA, Rice NSC. The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon"s fibroblasts. Invest Ophthalmol Vis Sic 1992;33:2043-2052.

(4) Traverso CE, Tomey KF, Antonios S. Limbal- Vs. fornix-based conjunctival Trabeculectomy flaps. Am J Ophthalmol 1987;104:28-32.

(5) Brincker P, Kessing SV. Limbus-based versus fornix-based conjunctival flap In glaucoma filtering surgery. Acta Ophthalmol (copenh) 1992;70:641-644.

(6) El Sayyad F, El-Maghraby A, Helal M. Fornix Based versus limbal-based conjunvtival flap in trabeculectomy with 5- FU. AAO, Anaheim. Calif. 1991

(7) El Sayyad F, El-Rashood A, Helal M, Hisham M, El-Maghraby A. Fornix based versus limbal-based conjunctival flaps in initial trabeculectomy with postoperative 5-fluorouracil:four-year follow-up findings. J Glaucoma 1999;8:124-128.

(8) A. Alwitry, V patel, AW King. Fornix Vs. limbal-based trabeculectomy with mitomycin C. Eye 2005;19:631-636

(9) Cystic Bleb Formation and Related Complications in Limbus-Versus Fornix Based Conjunctival Flaps in Pediatric and Young Adult Trabeculectomy With Mitomycin C. Ophthalmology 2003;110:2192-2197.

(10) Katz GJ, Higginbotham EJ, Licher PR. et al.:Mitomycin C versus 5-flourouracil in high-risk glaucoma filtering surgery. Ophthalmology 1995, 102:1263-1269.

(11) Akarsu C, Onol M, Hasanreisoglu B: Postoperative 5-flourouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up. Clin Exp Ophthalmol 2003, 31:199-205.

(12) Greenfield DS, Liebmann JM, Jea J. et al.:Lato-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998. 116:443-447.

(13) Fonnin LA, Schillman JC, Bundez DL:Risk factors for hypotony maculopathy Ophthalmology 2003. 110:1185-1191.

(14) Higginbotham EJ, Stevens RK, Musch DC. et al.:Bleb related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996. 103:650-656.

(15) Singh K, Mehta K, Shaikh NM. et al.: Trabeculectomy with intraoperative mitomycin C versus 5-flourouracil. Prospective randomized clinical trial. Ophthalmology 2000. 107:2305-2309.

(16) WuDunn O, Canlor LB, Polanca-Capistrano AM; et al.: A prospective randomized trial comparing intraoperative 5-flourouracil versus mitomycin C in primary trabeculectomy. Am J Ophthalmol 2002. 134:521-528.

(17) Joshi A, Parrish R, Feuer W. 2002 Survey of the American Glaucoma Society Practice Preferences for Glaucoma Surgery and Antifibrotic Use. J Glaucoma 2005;14:172-174.

(18) Helal M, El Sayyaad F, et al.:Trabeculectomy with adjunctive post-operative topical Mitomycin (MMC) in uncomplicated glaucoma. AAO, New Orleans, LSU. 2001

(19) El Sayyad F, Belmekk M, Helal M, Khalil M, El Hamzawy H, Hisham M. Simultaneous Subconjunctival and Subscleral Mitomycin-C Application in Trabeculectomy. Ophthalmology, 2000;107(2):298-301.

(20) You YA, Gu YS, Fang CT, Ma XQ. Long term effects of simultaneous Subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. J Glaucoma 2002;11:110-118.

(21) Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy After trabeculectomy with subconjunctival 5-fluorouracil.Am J Ophthalmol 1992;114:544-53.
(22) Jones E, Clarke J, Khaw P. Recent advances in trabeculectomy technique. Current opinion in Ophthalmology 2005;16:107-113

(23) Wilkins M, Occleston N, Kotecha A, Waters L, Khaw P. Sponge delivery variables and tissue levels of 5-fluorouracil. Br J Ophthalmol 2000;84:92-97.

(24) Khaw P, Sherwood M, MacKay S, Rossi M, Schultz G. 5-minute treatments with fluorouracil, floxuridine and mitomycin have long- term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol. 1992;110:1150-1154.

(25) Kitazawa Y, Suemori- matsushita H, Yamamoto T, Kawase K.Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma.Ophthalmology.1993;100:1624-8.

(26) Khaw pt, Doyle lW, Sherwood MB,et al. prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol. 1993;111:263-7.

(27) Megevand GS, Salmon JF, Scholtz RP, Murray AD. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology.1995;102:84-90.

(28) Neelakantan A, Rao BS, Vijaya l, et al. Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophtalmic Surg. 1994;25:612-15.

(29) Wilkins MR, Occleston NI, Kotecha A, et al.sponge delivery variables and tissue levels of 5-fluorouracil. Br J Ophthalmol. 1999;84:92-7.

(30) The Fluorouracil Filtering Surgery Group. Five-year followup of the fluorouracil filtering surgery study. Am J Ophthalmol.1996;121:349-66.

(31) Kitazawa Y,Kawase K,Mastsushita ll, Minobe M.Trabeculectomy with mitomycin . A comparative study with fluorouracil .Arch Ophthalmol. 1991;109:1693-8.

(32) Khaw P, Sherwood M, Mackay S, et al.: Five-minute treatments with fluorouracil, floxuridine , and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol.1992;110:1150-4.

(33) Sunaric-Megevand G, Leuenberger PM. Results of viscocanalostomy for primary open-angle glaucoma. Am J Ophthalmol 2001; 132: 221-228.

(34) El Sayyad F, Helal M, El Kholify H, Khalil M, El Mghraby A. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 2000; 107:1671-1674.

(35) The AGIS Investigators. The advanced glaucoma intervention study (AGIS). The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-440.

(36) Collaborative Normal Tension Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-497.

(37) Demailly P, Lavat p, Kretz G, Jeanteur-Lunel MN (1996-1997) Non-penetrating deep sclerectomy (NPDS) with or without collagen device(CD) in primary open-angle glaucoma: middle term retrospective study. Int Ophthalmol 20:131-40.

(38) Annad N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005; 19: 442-450

(39) Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J glaucoma 2002; 11: 287-293.
(40) Wishart PK, Austin MW. Combined cataract extraction and trabeculectomy: phacoemulsification compared with extracapsular technique. Ophthalmic Surg 1993; 24:814¬821

(41) Weitzman M, Caprioli L. Temporal corneal phacoemul¬sification combined with separate-incision superior trabeculectomy. Ophthalmic Surg 1995; 26:271-273

(42) El Sayyad F, Helal M. et al.: One site versus two sites phacotrabeculectomy: A randomized study. J CATARCTREFRACT. Surg. 1999; 25:77-82.

(43) Herris HL, Stewart WC. The use of 5-FU in patients following combined trabeculectomy and cataract extraction. Ophthalmic Surg 1991 22; 451-454.

(44) Ron J, Shine D, O’Grady J, et al.: Long-term outcome of primary glaucoma triple procedure with adjunctive 5FU. Grantos Arch Exp Ophthalmol 1998;236: 501-506.

(45) Shin DH, Ren J, Juzych MS, et al.: Primary glaucoma ripple procedures in patients with primary open angle glaucoma the effect of Mitomycin C in patient with and without prognostic factors for filteration failure. Am J Ophthalmol 1998; 125 345-352.

(46) Jample HD, Freidman DS, Lubomeki LH. et al.: Effect of technique on intraocular pressure after combined cataract and glaucoma surgery. Ophthalmology 2002 109;2215-2224.

(47) Cohen JS, Grell IJ, Novac GD. et al.:A placebo-controlled, double-masked Ophthalmology 1996. 103:1934-1942.

(48) Carison DW, Alward WL, Barad JP. et al.:A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. Ophthalmology 1997. 104:719-724.

(49) Shin DH, Iskandar NG, Aheo JA. et al.:Long-term filterationand visual-field outcomes after primary glaucoma triple procedure with and without mitomycin C. Ophthalmology 2002. 109:1607-1611.

(50) Susanna R, Jr and the Latin American Glaucoma Society (SLAG) Investigators Partial Tenon’s capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery Br. J. Ophthalmol. 2003 87: 932.

(51) Prata JA Jr, Minckler DS, Mermoud A, et al. Effects of intraoperative mitomycin C on the function of Baerveldt glaucoma drainage implants in rabbits. J Glaucoma 1996;5:29–38

(52) Taglia DP, Perkins TW, Gongnon R. Comparison of the Ahmed glaucoma valve the krupin eye valve with disc and the double plated Molteno implant. J Glaucoma 2002, 11: 347-353.1758-1762.